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Introduction
E-cadherin is the main epithelial cell–cell adhesion molecule, 
and either it is functionally disrupted or its expression is lost 
  altogether during tumor progression (Berx and Van Roy, 2001; 
Conacci-Sorrell et al., 2002). The effect is likely to be direct, 
because reestablishing E-cadherin function in cadherin- defi  cient 
cell lines can reverse the invasive phenotype (Vleminckx et al., 
1991). Moreover, experiments in transgenic mice strongly suggest 
that loss of E-cadherin directly promotes the transition of a 
  benign adenoma into a carcinoma (Perl et al., 1998).
The mechanism by which E-cadherin suppresses invasive-
ness is still unclear. The intracellular domain of E-cadherin 
  interacts directly with β-catenin and p120 catenin (p120) via 
separate conserved interaction domains. β-Catenin binding was 
recently shown to be important for the anti-invasive properties 
of E-cadherin (Wong and Gumbiner, 2003), although neither 
increased cell adhesion nor reduced nuclear β-catenin signaling 
was required for this effect. Unlike β-catenin, p120 has not 
been implicated in E-cadherin–mediated suppression of inva-
siveness, although it mislocalizes to the cytoplasm of E-cadherin–
defi  cient cells. This altered localization of p120 in breast or 
colon carcinomas is prognostic for aggressive disease (Sarrio 
et al., 2004; Bellovin et al., 2005).
Epithelial-to-mesenchymal transition is a process associ-
ated with normal development and wound healing, but its aber-
rant regulation contributes to cancer progression and metastasis 
(Thiery, 2002). Epithelial-to-mesenchymal transition is associ-
ated with loss of E-cadherin expression and increased expres-
sion of mesenchymal cadherins. Indeed, overexpression studies 
have suggested that increased expression of mesenchymal cad-
herins (N-cadherin, R-cadherin, and cadherin 11) increases the 
motility and invasiveness of epithelial cells (Nieman et al., 
1999; Hazan et al., 2000; Feltes et al., 2002; Suyama et al., 
2002). It is currently unclear whether endogenous  mesenchymal 
cadherins are required for the increased motility/invasiveness 
of E-cadherin–defi  cient cells.
The Rho family of GTPases (e.g., RhoA, Rac1, and 
Cdc42) mediate cytoskeletal dynamics (Nobes and Hall, 1995) 
and are crucial regulators of both cell motility (Titus et al., 
2005) and cadherin-dependent cell adhesion (Braga, 2002). 
As such, Rho GTPases are thought either to promote intercellu-
lar adhesion or to induce cell migration, depending on signals 
received from the microenvironment. Signaling from the cad-
herin complexes to Rho GTPases is thought to depend on p120 
(Anastasiadis and Reynolds, 2001).
p120 catenin is essential for mesenchymal 
cadherin–mediated regulation of cell motility 
and invasiveness
Masahiro Yanagisawa and Panos Z. Anastasiadis
Mayo Clinic Comprehensive Cancer Center, Jacksonville, FL 32224
  D
uring epithelial tumor progression, the loss of 
E-cadherin expression and inappropriate expres-
sion of mesenchymal cadherins coincide with 
  increased invasiveness. Reexpression experiments have 
established E-cadherin as an invasion suppressor. How-
ever, the mechanism by which E-cadherin suppresses in-
vasiveness and the role of mesenchymal cadherins are 
poorly understood. We show that both p120 catenin and 
mesenchymal cadherins are required for the invasiveness 
of E-cadherin–deﬁ  cient cells. p120 binding promotes the 
up-regulation of mesenchymal cadherins and the activa-
tion of Rac1, which are essential for cell migration and in-
vasiveness. p120 also promotes invasiveness by inhibiting 
RhoA activity, independently of cadherin association. 
  Furthermore, association of endogenous p120 with 
E-cadherin is required for E-cadherin–mediated suppression 
of invasiveness and is accompanied by a reduction in 
mesenchymal cadherin levels. The data indicate that p120 
acts as a rheostat, promoting a sessile cellular phenotype 
when associated with E-cadherin or a motile phenotype 
when associated with mesenchymal cadherins.
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Recent data indicate that p120 binding promotes the stabi-
lization of cadherin complexes on the plasma membrane and 
thus strengthens cell–cell adhesion (Davis et al., 2003; Xiao 
et al., 2003). In some cases, p120 can also negatively affect cell 
adhesion, although the mechanism of this effect remains  unclear. 
p120 overexpression induces dramatic changes in cell morphol-
ogy and increases cell motility (for review see Anastasiadis and 
Reynolds, 2001). These effects are apparently mediated by 
the ability of p120 to suppress RhoA activity (Anastasiadis 
et al., 2000; Noren et al., 2000) and induce the activities of the 
related Rho GTPases Rac1 and Cdc42 (Noren et al., 2000; 
  Grosheva et al., 2001). E-cadherin overexpression blocks the 
effects of p120 on cell morphology, suggesting that the recruit-
ment of p120 to E-cadherin complexes reduces its effects  toward 
Rho GTPases and possibly affects the balance between sessile 
and motile states.
Using E-cadherin–defi  cient cells, we show that endoge-
nous p120 mediates both the invasion-promoting effects of 
mesenchymal cadherins and the invasion-suppressing action of 
ectopically expressed E-cadherin. Endogenously expressed 
mesenchymal cadherins are essential for the invasiveness of 
E-cadherin–defi  cient cells, and their levels depend on p120 
  association. Furthermore, p120-induced Rac activation requires 
binding of p120 to mesenchymal cadherins and promotes inva-
siveness. p120 also promotes invasiveness by inhibiting RhoA 
in a cadherin-independent manner. The data indicate that en-
dogenous p120 is an important contributor to both the invasive 
phenotype of E-cadherin–defi  cient carcinomas and the sessile 
phenotype of E-cadherin–expressing epithelial cells.
Results
Endogenous p120 promotes invasiveness 
in E-cadherin–deﬁ  cient cells
To test whether endogenous p120 promotes the invasiveness 
of E-cadherin–defi  cient tumor cells, we measured the invasive-
ness of cells with diminished p120 expression. MDA-MB-231 
(MDA-231) and UMRC3 cells were infected with a retroviral 
vector (pRS) expressing short hairpin RNA (shRNA) targeted 
against human p120, as described previously (Davis et al., 
2003). UMRC3 cells are highly metastatic renal carcinoma cells 
that lack E-cadherin expression. Polyclonal cell populations 
with reduced p120 expression were tested for invasiveness in 
Matrigel-coated transwells toward a gradient of hepatocyte 
growth factor (HGF; MDA-231 cells) or 5% FBS (UMRC3 
cells). HGF was used as a chemoattractant because blocking 
HGF signaling prevents MDA-231 metastasis in nude mice 
  (Jiang et al., 2003). As shown in Fig. 1 A, reduction of endogenous 
p120 levels resulted in signifi  cantly reduced invasiveness in 
both cell lines. Next, we selected individual clones of shRNA-
expressing MDA-231 cells with varying expression of endoge-
nous p120 and tested their invasiveness toward HGF. Fig. 1 B 
demonstrates that the invasiveness of MDA-231 cells in vitro is 
proportional to the levels of endogenous p120. Control experi-
ments verifi  ed that cell line growth was not signifi  cantly af-
fected by p120 depletion under our experimental conditions. 
Identical results were obtained using anti-p120–specifi  c RNAi 
compared with control RNAi (unpublished data). Combined, 
the data strongly suggest that endogenous p120 is required for 
the invasiveness of E-cadherin–defi  cient cells.
Ectopic reexpression of p120, 
but not of a cadherin-uncoupled p120 
mutant, rescues motility and invasiveness
To further validate the in vitro invasion data, we measured cell 
migration using a scratch-wound assay. Within 12 h, control 
pRS/Neo-expressing cells moved to fi  ll in the wound much 
more effi   ciently than cells expressing human-specifi  c  p120 
shRNA (p120KD; Fig. 2 A). Expression of full-length murine 
p120 (mp120) in p120KD cells rescued cell migration in re-
sponse to HGF. The data argue that endogenous p120 mediates 
HGF-induced cell migration.
To address the possibility that p120 promotes motility by 
decreasing cell–cell adhesion, we performed cell aggregation–
disaggregation assays. Cells were allowed to form multicellu-
lar spheroid aggregates after overnight incubation in a hanging 
drop of media. Cell aggregates were then pipetted 10 times 
with a small bore tip, and the extent of cell disaggregation was 
assessed as a measure of adhesion strength. As can be seen in 
Fig. 2 B, ectopic expression of mp120 in p120KD cells moder-
ately increased cell–cell adhesion, suggesting that increased 
motility and invasiveness in response to p120 is not due to 
 reduced  adhesion.
Figure 1.  Endogenous p120 promotes invasiveness. (A) p120 depletion 
blocks invasiveness. E-cadherin–deﬁ   cient MDA-231 and UMRC3 cells 
were infected with control pRS retrovirus or with a retrovirus expressing 
anti-human p120-speciﬁ  c shRNA. Polyclonal cell populations were gener-
ated, and invasion assays were performed in vitro using 20 ng/ml HGF as 
a chemoattractant for MDA-231 cells or 5% FBS for the UMRC3 cells. After 
a 20-h incubation, cells on the underside of a Matrigel-coated transwell 
membrane were counted under a 20× objective (n = 6). (B) Endogenous 
p120 levels are directly correlated to cell invasion. MDA-231 cells were 
infected with control retrovirus or retrovirus expressing p120-speciﬁ  c 
shRNA. Individual clones of shRNA-expressing cells were selected and 
tested for levels of endogenous p120 and invasiveness in vitro, toward 
HGF (n = 6). (bottom) Lysates from all cell lines were subjected to SDS-
PAGE and Western blotted for expression of endogenous p120 (using 
mAb pp120) and actin. The two p120 bands correspond to p120 isoforms 
1 (top) and 3 (bottom). Error bars indicate SEM. *, P < 0.05; **, P < 0.01; 
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Finally, we examined the invasiveness of p120KD cells 
expressing murine p120 or a p120 mutant that lacks the fi  rst Ar-
madillo domain (A1) and is unable to associate with E-cadherin 
(Ireton et al., 2002). As shown in Fig. 2 C, expression of full-
length p120 reversed the p120KD effect and increased cell inva-
siveness. In contrast, ectopic expression of the p120 A1 mutant 
(mp120-A1) failed to rescue invasiveness. The data indicate 
that the effects of p120 depletion on cell invasion and motility 
are indeed p120 dependent. They also suggest that cadherin 
binding is required for the effects of p120 on invasion.
Endogenous mesenchymal cadherins 
promote the invasiveness 
of E-cadherin–deﬁ  cient epithelial cells
The inability of a cadherin-uncoupled p120 mutant to promote 
invasiveness suggested the possibility that in these E-cadherin–
defi  cient cells, p120 induces invasiveness via its association 
with mesenchymal cadherins. MDA-231 cells lack E-cadherin 
expression but express mesenchymal cadherin 11, whereas 
UMRC3 cells lack E-cadherin expression but express mesen-
chymal N-cadherin (unpublished data). Both of these cadherins 
have been shown to promote motility and invasiveness when 
overexpressed in tumor cells (Nieman et al., 1999; Hazan et al., 
2000). To test the possibility that endogenous p120 acts via 
mesenchymal cadherins to promote invasiveness, we initially 
expressed a short myc-tagged fragment of the E-cadherin cyto-
plasmic tail in MDA-231 cells. This small E-cadherin fragment 
(∆CB) binds avidly to p120, but not β-catenin, and recruits it to 
the cytosol away from any endogenous cadherins (Anastasiadis 
et al., 2000). As can be seen in Fig. 3 A, expression of ∆CB sig-
nifi  cantly reduced MDA-231 cell invasiveness. Furthermore, 
∆CB expression caused a marked reduction in endogenous cad-
herin 11 levels, consistent with the hypothesis that p120 binding 
regulates the levels of endogenous cadherins (Ireton et al., 2002; 
Davis et al., 2003; Xiao et al., 2003). To directly test whether 
endogenous p120 regulates the levels of mesenchymal cadher-
ins in E-cadherin–defi  cient cells, we determined the expression 
of mesenchymal cadherins after p120 depletion. Fig. 3 B shows 
that depletion of endogenous p120 reduced mesenchymal cad-
herin expression in both MDA-231 and UMRC3 cells.
Finally, to determine whether endogenously expressed 
mesenchymal cadherins promote invasion, we treated MDA-
231 and UMRC3 cells with siRNAs against cadherin 11 or 
N-cadherin, respectively, and measured cell invasiveness. In both 
cases, reduction of the endogenous mesenchymal cadherin levels 
resulted in signifi  cant inhibition of cell invasiveness, indicating 
that endogenous mesenchymal cadherins mediate motility and 
invasiveness in E-cadherin–defi  cient cells (Fig. 3 C).
Figure 2.  A cadherin-uncoupled p120 mutant does not promote motility 
and invasiveness. (A) Ectopic expression of murine p120 rescues the mi-
gration of p120-depleted cells. p120-depleted MDA-231 cells (clone 3; 
Fig. 1 B) were infected with control neo retrovirus or retrovirus expressing 
murine p120. After G418 selection, stable polyclonal cell lines were used 
in a scratch-wound assay to test their migration in response to HGF. Images 
shown are 0 and 12 h after HGF addition. The line denotes the cell front 
at time 0. The number of individual cells that crossed the line after 12 h 
was counted, and results were expressed as a percentage of migrating 
cells compared with control (MDA-231-pRS). n = 9. (B) The increased mi-
gration of p120-expressing cells is not due to reduced cell–cell adhesion. 
Cells were suspended as hanging drops and allowed to aggregate over-
night. The strength of cell adhesion was assessed after passing the cell 
  aggregates 10 times through a standard 200-μl pipette tip. Note that 
p120-expressing cells are more resistant to dissaggregation than cells de-
pleted of endogenous p120. (C) MDA-231 cells with knocked down ex-
pression of endogenous p120 (clone 3) were infected with retroviruses 
expressing neo resistance alone or together with full-length murine p120 or 
a murine p120 mutant (mp120-A1), which is unable to bind E-cadherin. 
The invasiveness of p120-reexpressing cells was tested in vitro toward 
HGF (n = 6). (bottom) Lysates from all cell lines were subjected to SDS-
PAGE and Western blotted for expression of p120 (using mAb pp120) and 
actin. Error bars indicate SEM. **, P < 0.01.
Figure 3.  Endogenous mesenchymal cadherins promote cell invasiveness. 
(A) Expression of the E-cadherin juxtamembrane domain inhibits cadherin 
11 levels and blocks invasiveness. MDA-231 cells were infected with con-
trol retrovirus (zeo) or retrovirus expressing a small, p120-binding, myc-
tagged fragment of the E-cadherin cytoplasmic tail (∆CB) that cannot 
associate with β-catenin. Polyclonal stable cell lines were subjected to inva-
sion assays, toward a gradient of HGF (n = 6). (bottom) Lysates from both 
cell lines were subjected to SDS-PAGE and Western blotted for expression 
of cadherin 11, ∆CB (using the myc tag–speciﬁ  c mAb 9E10), and actin. 
(B) p120 regulates the levels of endogenous mesenchymal cadherins. Poly-
clonal populations of p120-depleted MDA-231 or UMRC3 cells were ex-
amined for their expression of cadherin 11 or N-cadherin, respectively. 
Note that upon p120 depletion (top), levels of endogenous mesenchymal 
cadherins (middle and graphs) are reduced (n = 3). (C) Endogenous mes-
enchymal cadherins promote cell invasiveness. MDA-231 and UMRC3 
cells were transiently transfected by electroporation with either control 
siRNA or siRNA speciﬁ  c for human cadherin 11 or N-cadherin, respec-
tively. Control experiments veriﬁ  ed maximal knock down of cadherin ex-
pression 3 d after transfection. 2 d after transfection, cells were serum 
starved overnight and plated in Matrigel-coated transwells. Invasiveness 
was determined 24 h later in response to a gradient of HGF (MDA-231) or 
serum (UMRC3). n = 6. Error bars indicate SEM. *, P < 0.05; **, P < 0.01; 
***, P < 0.001.JCB • VOLUME 174 • NUMBER 7 • 2006  1090
p120 association promotes endogenous 
mesenchymal cadherin expression 
and invasiveness
The data in Fig. 3 suggested that one way by which p120 pro-
motes invasiveness is by binding to and regulating the levels of 
mesenchymal cadherins. Consistent with this hypothesis, the 
E-cadherin–uncoupled p120 A1 mutant was unable to promote in-
vasiveness when expressed in p120KD cells (Fig. 2 C). However, 
it is not known whether this p120 mutant (p120-A1) is also un-
able to associate with mesenchymal cadherins and whether its 
expression affects mesenchymal cadherin levels. To answer the 
fi  rst question, we performed coimmunoprecipitation assays us-
ing full-length p120 as a control. As shown in Fig. 4 A, ectopi-
cally expressed murine p120 coprecipitated with endogenous 
cadherin 11 from MDA-231 cells, whereas the p120-A1 mutant 
did not. Similar results were also obtained for N-cadherin 
  (unpublished data), indicating that the p120-A1 mutant is uncou-
pled from both epithelial and mesenchymal cadherins.
As shown earlier, p120 depletion caused a reduction in 
mesenchymal cadherin levels (Fig. 3 C). Fig. 4 B shows that 
p120 reexpression increased the levels of both cadherin 11 and 
N-cadherin in MDA-231 and UMRC3 cells, respectively. In 
contrast, expression of the cadherin-uncoupled p120-A1 mutant 
had no effect on mesenchymal cadherin expression, in agree-
ment with a requirement for p120 association.
We next tested the ability of a p120-uncoupled N-cadherin 
mutant to promote invasiveness. Fig. 4 C shows that ectopic 
expression of murine N-cadherin in UMRC3 cells depleted of 
endogenous N-cadherin rescued cell invasiveness. However, ex-
pression of a p120-uncoupled N-cadherin mutant (N-cad-AAA; 
Chen et al., 2003) failed to promote invasiveness. The data argue 
that p120 promotes motility and invasiveness by binding to mes-
enchymal cadherins. The association promotes cadherin stabil-
ity and possibly signaling events that induce cell migration.
p120-mediated Rac activation requires 
mesenchymal cadherin binding
Having established that p120 and mesenchymal cadherins are 
required for cell motility and invasiveness, we next examined 
possible mechanisms for this action. Given the ability of p120 
to affect the activity of Rho-family GTPases, we fi  rst asked 
whether p120 and mesenchymal cadherins cooperatively regu-
late the activity of Rho GTPases in E-cadherin–defi  cient cells.
Initially, we examined the activity of Rac1 in control 
cells (pRS-neo), p120-depleted cells (p120KD-neo), and cells 
reexpressing p120 (p120KD-mp120), under basal, serum-
starved conditions. As shown in Fig. 5 A, under basal condi-
tions, p120 depletion resulted in signifi  cant reduction of Rac1 
activity, which was reversed by expression of murine p120. 
p120 depletion also affected Rac1 activity of HGF-treated 
cells. Fig. 5 B shows that Rac1 activity was increased in con-
trol pRS-neo cells treated with HGF but not in p120-depleted 
cells (p120KD-neo). Expression of murine p120 in p120-
  depleted cells (p120KD-mp120) restored HGF-mediated Rac1 
activation. In contrast, expression of the cadherin-uncoupled 
p120-A1 mutant failed to restore Rac1 activation, suggesting 
that p120-mediated activation of Rac1 requires mesenchymal 
cadherin binding.
Finally, if the ability of p120 to induce Rac1 activation re-
quires cadherin association, depletion of endogenous cadherins 
should block p120-mediated Rac1 activation. To test this, we 
used either control p120-depleted cells (p120KD-neo) or p120-
depleted cells reexpressing p120 (p120KD-mp120). Rac1 acti-
vation in response to HGF (Fig. 5 B) is p120 dependent under 
these conditions. Fig. 5 C shows that the ability of p120 to me-
diate HGF-induced Rac1 activation depends on the levels of 
cadherin 11, as a cadherin 11–specifi  c siRNA blocks p120-
  mediated Rac1 activation, whereas a control siRNA has no effect. 
As expected, cadherin 11 depletion also inhibited HGF-induced 
Rac1 activation in parental MDA-231 cells (unpublished data). 
Collectively, these data strongly argue that the p120-mediated 
activation of Rac1 requires association of p120 with mesenchy-
mal cadherins.
Figure 4.  p120 binding regulates the levels of endogenous mesenchymal 
cadherins. (A) The p120-A1–deletion mutant does not bind mesenchymal 
cadherins. Lysates of p120-depleted MDA-231 cells (clone 3) reexpressing 
murine p120 (mp120) or a murine p120 mutant lacking the ﬁ  rst armadillo 
domain (mp120-A1) were immunoprecipitated with the murine p120-
  speciﬁ  c mAb 8D11. Precipitates were then subjected to SDS-PAGE and West-
ern blotted for the presence of cadherin 11 or p120. As shown, cadherin 
11 coimmunoprecipitates with wt p120 but not with mp120-A1. (right) Ex-
pression of cadherin 11 in total cell lysates of both cell lines. (B) The p120-
A1–deletion mutant does not regulate the levels of endogenous mesenchymal 
cadherins. p120-depleted MDA-231 cells (clone 3) stably expressing con-
trol neo, mp120, or mp120-A1 were lysed and subjected to SDS-PAGE 
and Western blotted for expression of p120, cadherin 11, or actin as a 
loading control (left). (right) Similar Western blots of p120-depleted 
UMRC3 cells blotted for expression of N-cadherin. In both cases, reexpres-
sion of mp120, but not mp120-A1, increases mesenchymal cadherin lev-
els. (C) p120 binding is required for the invasion-promoting effects of 
N-cadherin. UMRC3 cells were transiently transfected with human N-
  cadherin–speciﬁ  c siRNA together with control YFP, murine N-cadherin–YFP, 
or N-cad-AAA-YFP, a murine N-cadherin mutant unable to bind p120 
(N-cad-AAA). In contrast to wt N-cadherin, N-cad-AAA failed to promote 
invasiveness. Error bars indicate SEM. *, P < 0.05; **, P < 0.01.P120 CATENIN AND CELL INVASIVENESS • YANAGISAWA AND ANASTASIADIS 1091
The p120-mediated inhibition of RhoA 
in E-cadherin–deﬁ  cient cells is independent 
of mesenchymal cadherin expression
Previous studies have shown that p120 overexpression decreases 
RhoA activity (Anastasiadis et al., 2000; Noren et al., 2000; 
Grosheva et al., 2001). Thus, we examined the effect of p120 on 
RhoA activity under either basal (serum-starved) conditions or 
after HGF treatment. Fig. 6 A shows that under basal conditions, 
RhoA activity was signifi  cantly increased in p120-depleted cells 
(p120KD-neo) when compared with control cells (pRS-neo). 
Consistent with the increased RhoA activity, p120-depleted 
cells were fl  atter and contained more stress fi  bers than control 
cells (unpublished data). Expression of murine p120 reduced 
basal RhoA activity levels and restored normal cell morphology, 
indicating that p120 regulates RhoA activity. Similar results 
were obtained when cells were treated for 20 min with HGF; 
control cells and p120-reexpressing cells exhibited reduced Rho 
activity compared with p120-depleted cells (Fig. 6 B).
We then asked whether the p120-mediated reduction of 
RhoA activity requires binding to endogenous cadherins.  Again, 
we used p120-depleted (p120KD-neo) and p120-reexpressing 
cells (p120KD-mp120) and examined RhoA activity in response 
to HGF treatment in the presence of cadherin 11 or control 
siRNA. Fig. 6 C shows that p120 can suppress RhoA activity 
even in cadherin 11–depleted cells, suggesting that cadherin 11 
is not required for p120-induced RhoA inhibition. This conclu-
sion was corroborated by the observation that the cadherin-
  uncoupled p120 A1 mutant, like wild-type (wt) p120, inhibits 
Figure 5.  p120-mediated Rac activation requires mesenchymal cadherin 
binding. (A) Endogenous p120 regulates basal Rac1 activity. Levels of total 
and GTP-bound Rac1 were determined in serum-starved control MDA-231 
cells (pRS-neo), p120-depleted cells (p120KD-neo), or cells reexpressing 
p120 (p120KD-mp120). Data are also expressed as a percentage of Rac1 
activity, determined by densitometric analysis of immunoblots compared 
with the pRS-neo controls (n = 6). (B) p120 regulates HGF-induced Rac1 
activity. Levels of total and GTP-bound Rac1 were determined in the same 
serum-starved cell lines as above, as well as in p120KD cells expressing 
mp120-A1, after incubation for 15 min with HGF. Both the p120-depleted 
cells and cells expressing mp120-A1 failed to induce Rac1 in response to 
HGF. Data are also expressed as a percentage of Rac activity at time 0 
(control). n = 3. (C) Cadherin 11 is required for p120-dependent Rac1 in-
duction. p120KD MDA-231 cells expressing either neo control or mp120 
were transiently transfected using electroporation with control or cadherin 
11 siRNA. Cells were then serum starved overnight, and the activity of 
Rac1 was determined using pull-down assays after a 15-min incubation 
with HGF. Data was also expressed as a percentage of Rac1 activity com-
pared with the neo controls (n = 6). Error bars indicate SEM. *, P < 0.05; 
**, P < 0.01.
Figure 6.  p120 inhibits RhoA independently of mesenchymal cadherin 
expression. (A) Endogenous p120 regulates basal RhoA activity. Levels of 
total and GTP-bound RhoA were determined in serum-starved control MDA-
231 cells (pRS-neo), p120-depleted cells (p120KD-neo), or cells reexpress-
ing p120 (p120KD-mp120). Densitometric analysis of immunoblots was 
used to express the data as a percentage of RhoA activity, as compared 
with the pRS-neo controls (n = 6). (B) p120 regulates HGF-induced effects 
on RhoA activity. RhoA activity was determined in the same cell lines as ex-
plained above after incubation for 20 min with HGF. Data are also ex-
pressed as a percentage of Rho activity at time 0 (n = 3). (C) Cadherin 11 
is dispensable for p120-dependent RhoA inhibition. p120KD MDA-231 
cells expressing neo control or mp120 were transiently transfected with 
control or cadherin 11 siRNA. Cells were then serum starved overnight, 
and the activity of RhoA was determined after a 20-min incubation with 
HGF. Treatment with cadherin 11 siRNA failed to block the p120-mediated 
inhibition of RhoA under these conditions (n = 3). (D) The cadherin-uncoupled 
p120-A1 mutant can inhibit RhoA activity. p120-depleted MDA-231 cells 
expressing neo control or mp120-A1 were subjected to Rho pull-down 
  assays to determine levels of active RhoA after 20 min of HGF treatment. 
Data are also expressed as a percentage of RhoA activity (n  = 6). 
(E) mp120-A1 can induce “branching” in NIH3T3 cells. NIH3T3 cells were 
transiently transfected with mp120, mp120-A1, or pcDNA control. 24 h 
later, cells were ﬁ  xed in methanol and stained for p120 with mAb 12F4. 
Photographs show the characteristic branching phenotype of p120-over-
expressing cells. Error bars indicate SEM. *, P < 0.05; **, P < 0.01.JCB • VOLUME 174 • NUMBER 7 • 2006  1092
RhoA activity in MDA-231 cells (Fig. 6 D). Finally, like 
wt p120, which when overexpressed induces a branching mor-
phology by inhibiting RhoA activity (Anastasiadis et al., 2000), 
mp120-A1 was able to induce a branching morphology in 
NIH3T3 cells (Fig. 6 E). The data suggest that, unlike p120-
mediated Rac1 activation, the p120-mediated inhibition of 
RhoA is independent of mesenchymal cadherin expression in 
these cells.
Rho GTPases regulate the invasiveness 
of E-cadherin–deﬁ  cient tumor cells
We next sought to establish that the p120-mediated changes in 
Rho GTPase activities were related to the increased cell migra-
tion and invasiveness of E-cadherin–defi  cient cells. First, we 
overexpressed constitutively active or dominant-negative Rac1 
in MDA-231 cells and measured the in vitro invasiveness of 
  serum-starved cells toward a gradient of HGF. Expression of 
dominant-negative Rac1 (DN-Rac1) signifi  cantly reduced cell 
invasiveness (Fig. 7 A), suggesting that Rac1 activation is re-
quired for HGF-induced invasiveness. Ectopic expression of 
constitutively active Rac1 did not increase cell invasiveness 
over cells expressing a vehicle control (pcDNA), suggesting 
that parental MDA-231 cells maximally activate Rac1 in re-
sponse to HGF (unpublished data). To test the potential involve-
ment of Rho activation in the invasiveness of MDA-231 cells, 
we expressed constitutively active RhoA and measured cell in-
vasiveness in response to HGF. As shown in Fig. 7 A, increased 
levels of active RhoA signifi  cantly reduced the invasiveness of 
MDA-231 cells.
To directly correlate changes in Rho GTPase activities 
with p120-induced invasiveness, we tested whether activation 
of Rac1 and inhibition of RhoA signaling can restore the inva-
siveness of p120-depleted cells. As shown in Fig. 7 B, stable 
expression of constitutively active Rac1 (CA-Rac1) in p120-
  depleted MDA-231 cells increased invasiveness toward HGF 
in vitro. Inhibition of Rho signaling by incubating p120-depleted 
cells expressing CA-Rac1 with a Rho kinase inhibitor (H1152; 
1.6 nM; Ikenoya et al., 2002) further promoted cell invasive-
ness. Together, the data argue that changes in Rac and Rho sig-
naling are causally involved in p120-mediated effects on cell 
motility and invasiveness.
The suppression of cell migration 
and invasiveness by E-cadherin requires 
p120 binding and reduced expression 
of mesenchymal cadherins
Having established that endogenous p120 promotes the invasive 
behavior of E-cadherin–defi  cient cells, we tested the hypothesis 
that recruitment of p120 to E-cadherin can suppress  invasiveness. 
Ectopic expression of wt human E-cadherin in MDA-231 or 
UMRC3 cells was accomplished by retroviral infection, fol-
lowed by G418 selection. More than 95% of infected cells ex-
pressed E-cadherin under these conditions. As shown in Fig. 8 A, 
MDA-231 cells infected with a control neo virus express no 
E-cadherin, have primarily cytoplasmic p120 staining, and ex-
hibit scattered cell morphology. In contrast, cells expressing wt 
E-cadherin form epithelial colonies in which p120 is recruited 
to the E-cadherin–mediated cell–cell junctions. Identical results 
were also obtained with UMRC3 cells. The ectopic expression 
of E-cadherin signifi  cantly inhibited cell migration (Fig. 8 B) 
and blocked the ability of either MDA-231 or UMRC3 cells to 
invade in vitro (Fig. 8 C). Together, these experiments establish 
that both cell lines represent excellent model systems for study-
ing the mechanism by which E-cadherin suppresses invasive-
ness and the possible involvement of p120.
Next, we compared the invasiveness of MDA-231 cells 
expressing a p120-uncoupled E-cadherin mutant (764-AAA; 
Thoreson et al., 2000) to that of control cells or cells expressing 
wt E-cadherin. As shown in Fig. 8 D, cells expressing the p120-
uncoupled 764-AAA E-cadherin mutant were signifi  cantly 
more invasive than cells expressing wt E-cadherin but not as in-
vasive as the neo controls. Control experiments verifi  ed that 
both cadherins were expressed at comparable levels and that 
cells expressing the p120-uncoupled E-cadherin mutant do form 
colonies and recruit β-catenin to the membrane (unpublished 
data; Thoreson et al., 2000).
To directly implicate endogenous p120 in E-cadherin–
mediated suppression of invasiveness, we used two compli-
mentary approaches. In the fi  rst, we overexpressed p120 in 
E-cadherin–expressing cells. In the second, we inhibited p120 
function in cells expressing the p120-uncoupled E-cadherin 
mutant. Fig. 9 A shows that p120 overexpression increased the 
invasiveness of wt E-cadherin–expressing cells in vitro, sug-
gesting that recruitment of endogenous p120 by E-cadherin 
suppresses invasion. Furthermore, the invasiveness of cells ex-
pressing the 764-AAA E-cadherin mutant was potently blocked 
Figure 7.  Restoration of Rho GTPase signaling rescues the invasiveness of 
p120-depleted cells. (A) Inhibition of Rac1 and activation of RhoA activities 
block MDA-231 cell invasiveness. MDA-231 cells were transiently trans-
fected by electroporation with a control pcDNA construct or with a myc-
tagged pcDNA construct expressing either a dominant-negative N17-Rac1 
mutant (DN-Rac1) or a constitutively active V14-RhoA mutant (CA-RhoA). 
2 d after transfection, cells were plated in transwell ﬁ  lters, and invasion assays 
were performed a day later using HGF as a chemoattractant (n = 6). The 
expression of DN-Rac1 or CA-RhoA was monitored in cell lysates using the 
myc tag–speciﬁ  c mAb 9E10. (B) Activation of Rac1 and inhibition of Rho 
signaling promote invasiveness in p120-depleted cells. p120-depleted MDA-
231 cells were infected either with retrovirus expressing control neo or with 
constitutively active Rac1. Stable cell lines were subjected to invasion assays 
in either control media or media containing a Rho kinase inhibitor (H-1152; 
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by coexpression of ∆CB, the small cytoplasmic fragment of 
E-cadherin that binds selectively to p120 but not β-catenin. 
The data suggest that the increased invasiveness of cells ex-
pressing p120-uncoupled E-cadherin is due to its inability to 
recruit endogenous p120 to the E-cadherin complex. To con-
fi  rm this hypothesis, we examined the effect of p120 depletion 
on the invasiveness of cells expressing the p120-uncoupled 
E-cadherin mutant. Retroviral expression of p120-specifi  c shRNA, 
but not control shRNA, signifi  cantly reduced the invasiveness 
of these cells (Fig. 9 B). Examination of individual p120 
shRNA clonal lines with varied endogenous p120 expression 
indicated that cell invasion is directly correlated with endoge-
nous p120 levels (Fig. 9 B). Collectively, the data indicate that 
p120 binding is required for E-cadherin–mediated suppression 
of invasiveness.
Finally, we also examined the effects of E-cadherin re-
expression on the levels of endogenous mesenchymal cad-
herins. As can be seen in Fig. 9 C, E-cadherin expression in 
MDA-231 cells resulted in a marked reduction of cadherin 
11 levels. The data are consistent with the hypothesis that 
p120 recruitment to E-cadherin causes the loss of p120 bind-
ing to mesenchymal cadherins and subsequent reduction of 
their protein levels. Indeed, expression of p120-uncoupled 
E-cadherin largely reverses the loss of mesenchymal cadherin 
expression observed in cells expressing wt E-cadherin and, as 
shown earlier (Fig. 9 A), restores their invasiveness. Similar 
results were observed in UMRC3 cells (which express 
N-  cadherin), demonstrating that this effect is not restricted 
to MDA-231 cells (unpublished data).
Figure 8.  p120-uncoupled E-cadherin is less able to suppress invasive-
ness. (A) Ectopic E-cadherin recruits p120 to cell junctions. MDA-231 
cells were infected with retroviruses expressing neomycin resistance 
alone or in combination with wt E-cadherin. More than 95% of G418-
  selected cells expressed wt E-cadherin. Wt E-cadherin accumulated at ar-
eas of cell–cell contact (mAb HECD-1). Endogenous p120 was primarily 
cytoplasmic in control cells and was recruited to cell–cell junctions 
in cells expressing wt E-cadherin (detected with polyclonal antibody 
F1αSH). (B) E-cadherin expression suppresses cell migration. After over-
night serum starvation, conﬂ  uent monolayers of control neo cells or MDA-
231 cells expressing wt E-cadherin were scratched with a pipette tip, 
and cell migration into the wound was monitored over time in the pres-
ence of HGF. The number of individual cells that crossed the original cell 
front after 12 h was counted, and results were expressed as a percent-
age of migrating cells compared with neo control (n = 6). (C) E-cadherin 
suppresses cell invasiveness. The invasiveness of E-cadherin–expressing 
MDA-231 or UMRC3 cells was tested in vitro using HGF (MDA-231) or 
serum (UMRC3) as the chemoattractant (n = 6). (D) p120-uncoupled 
E-cadherin is less able to suppress invasiveness. Polyclonal populations 
of MDA-231 cells expressing neo control, wt E-cadherin, or a p120-
  uncoupled E-cadherin mutant (764-AAA) were subjected to invasion 
assays in response to HGF (n = 6). Error bars indicate SEM. **, P < 0.01; 
***, P < 0.001; 
++, P < 0.01, as compared with cells expressing 
wt E-  cadherin (ANOVA).
Figure 9.  p120 binding to E-cadherin suppresses invasiveness and 
  reduces mesenchymal cadherin levels. (A) E-cadherin–free p120 promotes 
invasiveness. MDA-MB-231 cells stably expressing wt E-cadherin or a 
p120-uncoupled E-cadherin mutant (764-AAA) were infected with retrovi-
ruses expressing zeomycin resistance alone (zeo) or together with murine 
p120 or ∆CB. ∆CB is a myc-tagged truncation mutant of the E-cadherin cy-
toplasmic domain, which binds p120 but not β-catenin. Invasion assays 
using HGF as chemoattractant were performed as described earlier (n = 6). 
(bottom) Lysates from all four cell lines were subjected to SDS-PAGE and 
Western blotted for expression of exogenous p120 (mAb 8D11 recognizes 
murine but not endogenous human p120), ∆CB (9E10), and actin as a 
loading control. (B) Endogenous p120 promotes the invasiveness of p120-
uncoupled E-cadherin in a dose-dependent manner. MDA-231 cells ex-
pressing the p120-uncoupled 764-AAA E-cadherin mutant were infected 
with control pRS retrovirus or viruses expressing p120-speciﬁ  c  shRNA. 
  Individual clones of shRNA-expressing cells were selected and examined 
for levels of endogenous p120 and in vitro invasiveness toward HGF (n = 6). 
Note that levels of endogenous p120 in the clonal cell lines correlate 
  directly to their invasiveness in vitro. (C) p120 recruitment to E-cadherin 
  inhibits cadherin 11 levels. Lysates of MDA-231 cells stably expressing 
control neo, wt E-cadherin, or the p120-uncoupled 764-AAA E-cadherin 
mutant were subjected to SDS-PAGE and Western blotted for cadherin 11 
levels or actin as a loading control. (top) Cadherin 11 levels are also ex-
pressed as a percentage of neo control (n = 3). Error bars indicate SEM. 
*, P < 0.05; **, P < 0.01.JCB • VOLUME 174 • NUMBER 7 • 2006  1094
Discussion
Several previous studies have suggested that overexpression of 
p120 catenin (Noren et al., 2000; Grosheva et al., 2001) or over-
expression of mesenchymal cadherins (Nieman et al., 1999; 
Hazan et al., 2000; Johnson et al., 2004) promotes cell  migration. 
We have used E-cadherin–defi   cient cancer cells to test the 
  hypothesis that p120 is required for the increased migration and 
invasiveness of these cells in vitro. The results reveal an essen-
tial role for p120 in both the migration and invasiveness of these 
cells and an unexpected role in mediating the proinvasive func-
tion of endogenous mesenchymal cadherins. Remarkably, asso-
ciation of endogenous p120 with E-cadherin is required for 
E-cadherin–mediated suppression of invasiveness and is ac-
companied by a concomitant reduction in mesenchymal cad-
herin levels. Mechanistically, p120 seems to regulate migration 
and invasiveness via three seemingly independent pathways: (1) 
the p120 association–dependent regulation of mesenchymal 
cadherin levels, (2) the induction of Rac1 activity after mesen-
chymal cadherin binding, and (3) the cadherin-independent 
  inhibition of RhoA.
Our data demonstrate that mesenchymal cadherins are 
  essential for the migration and invasiveness of E-cadherin–
 defi  cient tumor cells and that both the physical and the functional 
interaction with p120 are required for the proinvasive function 
of mesenchymal cadherins. The data are also consistent with a 
recent study suggesting that the p120-binding juxtamembrane 
domain of cadherin 11 is responsible for cadherin 11–mediated 
cell motility (Kiener et al., 2006).
It has been proposed that p120 mediates its effects on cell 
migration through regulation of Rho GTPases (for review see 
Anastasiadis and Reynolds, 2001). Interestingly, we show that 
both the basal and HGF-induced Rac1 activities are inhibited by 
p120 depletion. Furthermore, experiments using cadherin 11–
depleted cells or cadherin-uncoupled p120 mutants indicate that 
the p120-induced Rac1 activation requires mesenchymal cad-
herin association and are in agreement with recent data suggest-
ing that the p120-binding juxtamembrane domain is required 
for E-cadherin– or N-cadherin–induced Rac1 activation upon 
cell–cell adhesion (Goodwin et al., 2003; Gavard et al., 2004).
p120 depletion increased RhoA activity and decreased the 
activity of Rac1, providing a potential mechanistic explanation 
for the ability of dominant-active Rac mutants and dominant-
negative RhoA mutants to rescue the defects induced by p120 
depletion on Xenopus laevis gastrulation (Fang et al., 2004). 
However, unlike Rac activation, the data suggest that p120 in-
hibits RhoA in a cadherin-independent manner in these cells, in 
agreement with several previous investigations (Anastasiadis 
et al., 2000; Noren et al., 2000; Magie et al., 2002; Bellovin et al., 
2005; Perez-Moreno et al., 2006).
To address the involvement of Rho GTPases in the inva-
siveness of our E-cadherin–defi  cient cells, we initially demon-
strated that either reduced Rac1 or increased RhoA activities 
result in decreased cell invasiveness in vitro. Reduced Rac1 and 
increased RhoA activities mimic the effects of p120 depletion 
in these cells. Interestingly, activation of Rac1 and inhibition 
of RhoA signaling cooperatively restored the invasiveness of 
p120-depleted cells, arguing that changes in Rho GTPase sig-
naling are causally involved in p120-mediated effects on cell 
motility and invasiveness.
The observation that endogenous p120 promotes the ex-
pression of mesenchymal cadherins and increases the invasive-
ness of E-cadherin–defi  cient cells suggested the possibility that 
p120 is also involved in the invasion-suppressive function of 
E-cadherin. In the simplest scenario, E-cadherin association would 
reduce the amount of p120 available to bind mesenchymal cad-
herins and promote invasiveness. Indeed, we show that E-cadherin 
suppresses invasion, at least in part, by binding endogenous p120. 
Furthermore, as predicted, mesenchymal cadherin levels were 
signifi  cantly reduced upon the expression of wt E-cadherin 
but not the p120-uncoupled E-cadherin mutant (764-AAA). 
The data reveal an important role for p120 binding in E-
  cadherin–mediated suppression of invasiveness and regulation 
of the motile or sessile phenotype of epithelial cells. It should 
be noted that the invasiveness of 764-AAA E-cadherin–expressing 
cells was lower than that of neo controls (Fig. 8 D), suggesting 
that a portion of the invasion-suppressive function of E-cadherin 
may not be related to p120 binding. It is likely that other factors, 
including recruitment of β-catenin (Wong and Gumbiner, 2003), 
play important roles in this process.
Our data indicate that p120 binds to and cooperates 
with mesenchymal cadherins to activate Rac1 and promote 
motility and invasiveness. However, it is unclear why E-cadherin 
suppresses migration, despite its ability to activate Rac1 in a 
p120-dependent manner after its homophilic interaction. One 
possibility is that the activation of Rac1 in the context of cad-
herin ligation is effectively different from activation of Rac1 
in response to certain growth factors. In agreement with this, 
lamellipodium extension in response to cadherin activation is 
reportedly dependent on a PI-3-kinase–Rac1 pathway, whereas 
cadherin-mediated adhesion proceeds via a PI-3-kinase inde-
pendent, Rac1-dependent pathway; both responses require the 
membrane association of p120 with the cadherin complex (Gavard 
et al., 2004). In addition, E-cadherin may be less effective than 
mesenchymal cadherins in promoting Rac1 activation in response 
to promigratory signals, or it may be more capable of suppressing 
growth factor signaling by sequestering and preventing the 
ligand-dependent activation of their receptors (Qian et al., 2004). 
Another possibility is that the differential ability of cadherins to 
recruit p120 to cell junctions may result in differential regulation 
of Rho activities. In support of these possibilities, the increased 
migration of R-cadherin overexpressing BT-20 cells, which 
normally express E-cadherin, correlates with increased Rac1 
and reduced RhoA activities (Johnson et al., 2004),   suggesting 
that E-cadherin and mesenchymal cadherins differentially affect 
Rho GTPases.
Finally, it is important to note that collagen-mediated 
integrin signaling can switch the effect of increased Rac1 
activation from promoting E-cadherin–mediated adhesion to 
promoting cell migration (Sander et al., 1998). The data indicate 
that contextual signals can misdirect Rac signaling to promote 
cell migration, even in the presence of E-cadherin. Clearly, 
  understanding the functional differences between E-cadherin 
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migration will be critical for understanding tumor progression 
to metastasis and events involved in tissue morphogenesis.
The data presented here imply that E-cadherin competes 
p120 away from mesenchymal cadherins, which then become 
destabilized. Further studies will be needed to address the rela-
tive affi  nities of p120 for different cadherins and how these 
 affi  nities are affected by posttranslational modifi  cations (e.g., 
p120 phosphorylation). It is possible that the functional disrup-
tion of the cadherin–catenin complex, which is often the result 
of Ras mutations or constitutive receptor tyrosine kinase signal-
ing, promotes a more invasive phenotype by reducing the affi  n-
ity of p120 for E-cadherin. As invasiveness was tested here 
using cell culture models, future studies are needed to show 
whether these results refl  ect invasive behavior in vivo. In any 
case, our data indicate that endogenous p120 acts as a rheostat, 
promoting a sessile cellular phenotype when associated with 
E-cadherin or a motile phenotype when associated with mesen-
chymal cadherins.
Materials and methods
Cell culture, infections, and transfections
Culture conditions have been described previously (Ireton et al., 2002). 
For shRNA expression, cells were infected with pRS and selected with 5 
μg/ml puromycin. As indicated, some cells were infected again with LZRS-
neo or -zeo and selected with 1 mg/ml G418 or 350 μg/ml zeocin. pRS 
and LZRS amphotropic retroviruses were produced as described previously 
(Davis et al., 2003). Clonal MDA-MB-231 cell lines were generated by 
limiting dilution. Amaxa electroporations were performed according to the 
company’s protocol. In brief, 10
6 cells were resuspended in 100 μl solu-
tion T (Amaxa) containing 2 μg of plasmid DNA. Electroporation was per-
formed using program A-23. Electroporated cells were plated in 60-mm 
dishes and incubated for 24 h in normal culture media. Cells were then 
washed in PBS and incubated for another 12 h in serum-free Dulbecco’s 
minimal essential medium.
Immunoﬂ  uorescence
Immunoﬂ  uorescence localization procedures have been described in detail 
(Thoreson et al., 2000). The following primary antibodies were used: 0.5 
μg/ml F1αSH p120 polyclonal antibody (Wu et al., 1998) and 1 μg/ml 
HECD-1 (Zymed Laboratories). The secondary antibodies used were goat 
anti-mouse Alexa 488 (Invitrogen) and goat anti-rabbit Alexa 596 at 
1:600. Cells were visualized under a ﬂ  uorescent microscope (DM5000B; 
Leica) using a 63×/1.4 HCX planApo oil objective (Leica). Photos were 
acquired with the FX4000 program (Leica) using a charge-coupled device 
camera (DFC350FX; Leica) and compiled in Photoshop (Adobe) and 
  PowerPoint (Microsoft).
Constructs
LZRS-mp120 isoform 1A-neo, LZRS-mp120 A1-neo, LZRS-wt-E-cadherin-
neo, and LZRS-764-AAA-neo were described previously (Ireton et al., 
2002). The pRS vector was a gift from R. Agami (The Netherlands Cancer 
Institute, Amsterdam, Netherlands). pRS human p120 shRNA was also 
described previously (Davis et al., 2003). LZRS-MS-zeocin was provided 
by A. Reynolds (Vanderbilt University, Nashville, TN) and encodes for 
zeocin instead of neomycin resistance. Initially, LZRS-∆CB-GFP was gener-
ated by subcloning an EcoRI fragment of pCAN-∆CB (Anastasiadis et al., 
2000) into the EcoRI site of LZRS-MS-GFP (LZRS-∆CB-GFP). LZRS-∆CB-
  zeocin was generated by subcloning a SgfI–Sﬁ  I fragment of LZRS-∆CB-GFP 
(containing ∆CB) into the respective sites of the LZRS-MS-zeocin vector. 
The RhoA-V14-myc (CA-RhoA), Rac1-V12-myc (CA-Rac1), and Rac1-
N17-myc (DN-Rac1) pcDNA3 constructs were all described previously 
  (Anastasiadis et al., 2000). Murine N-cadherin-YFP and N-cadherin-AAA-
YFP were provided by K.J. Green (Northwestern University, Chicago, IL; 
Chen et al., 2003). All constructs were veriﬁ  ed by sequencing. Smartpool 
siRNAs against human cadherin 11 and N-cadherin were obtained from 
Dharmacon. Silencing speciﬁ  city was conﬁ  rmed using ON-Targetplus non-
targeting siRNAs (Dharmacon).
Western blotting
Western blotting procedures were conducted as described previously 
  (Ireton et al., 2002). Primary antibodies were used as follows: 0.25 μg/ml 
anti-p120 mAbs pp120 and 1 μg/ml 8D11 (does not recognize human 
p120), anti–E-cadherin mAbs (1/2,500; C-20820; BD Biosciences) and 1 
μg/ml HECD-1 (Zymed Laboratories), 1 μg/ml anti–c-Met (C-28; Santa 
Cruz Biotechnology, Inc.), anti–β-catenin polyclonal antibody (1/1000; 
C2206; Sigma-Aldrich), 5 μg/ml anti-Flag tag mAb (M2; Sigma-Aldrich), 
1 μg/ml anti-myc tag (9E10; Sigma-Aldrich), anti–cadherin 11 antibodies 
(WTID1 [polyclonal antibody] and 5B2H5 [mAb]; Zymed Laboratories), 
and 0.6 μg/ml anti-actin goat polyclonal antibody (I-19; Santa Cruz Bio-
technology, Inc.). Secondary antibodies were peroxidase-conjugated don-
key anti–mouse IgG and mouse anti–rabbit IgG (Jackson ImmunoResearch 
Laboratories) and donkey anti-goat IgG (Santa Cruz Biotechnology, Inc.) 
used at 1:10,000.
Invasion assay
Cell invasion was measured in vitro using BioCoat Matrigel-coated inva-
sion chambers (8 μm pore size; Becton Dickinson). Culture medium was 
changed to Dulbecco’s minimal essential medium supplemented with 250 
μg/ml BSA, and cells were incubated overnight at 37°C. Cells were then 
harvested using Cell Stripper (Mediatech, Inc.), to prevent the proteolytic 
degradation of cadherins, and resuspended in Dulbecco’s minimal essen-
tial medium/BSA at a density of 5 × 10
5 cells/ml. 100 μl (5 × 10
4 cells) 
of cell suspension was added to the top chamber, whereas Dulbecco’s min-
imal essential medium/BSA containing either 20 ng/ml HGF (Reprotech, 
Inc.) or 5% FBS was added to the lower chamber as a chemoattractant. 
Cells were allowed to invade the Matrigel and migrate to the underside of 
the invasion chamber for 20 h at 37°C in 5% CO2. Cells on the top surface 
of the chamber were removed by gentle scrubbing with a cotton swab, and 
cells on the underside were stained with crystal violet and counted. Control 
experiments established that no growth differences existed between all cell 
lines tested under the conditions of this assay. Data from several experi-
ments were expressed as percentage of control and represent the mean ± 
SEM of at least three independent determinations performed in duplicate. 
One, two, and three asterisks represent P < 0.05, P < 0.01, and P < 
0.001, respectively (t test, or one way ANOVA followed by post-hoc com-
parisons using the Newman-Keuls test). The H-1152 Rho kinase inhibitor 
(Calbiochem) was used in some experiments at 1.6 nM, which is the 
  reported Ki for this compound.
Scratch-wound assay
Cells were harvested using Cell Stripper, washed twice in PBS, and resus-
pended at 1 × 10
6 cells/ml in Dulbecco’s minimal essential medium. 3 × 10
5 
cells in 300 μl of media were then cultured in 4-well chamber slides 
(Nunc). 24 h later, cells were washed again with PBS and supplemented 
with serum-free media for 12 h. Conﬂ  uent cell monolayers were scratched 
using a 200-μl Finnpipette tip, and serum-free medium containing 20 ng/ml 
HGF was added to the cells. Migration of cells into the wound was 
  monitored in multiple wells using a live cell imaging workstation (AS-MDW; 
Leica) with a 20×/04 N Plan objective. Images were captured every 
60 min, and images shown represent 0 and 12 h after HGF addition.
Aggregation assay
Cells were tested for their ability to aggregate in hanging drop suspension 
cultures, as previously described (Thoreson et al., 2000). In brief, cells 
were suspended using Cell Stripper, washed in PBS, and resuspended in 
Dulbecco’s minimal essential medium. 1.5 × 10
5 cells in 30 μl of media 
were suspended as hanging drops from the lid of a 24-well culture dish 
and allowed to aggregate overnight in a humid 5% CO2 incubator at 
37°C. Aggregation was assessed 18 h after plating. To assay for tightness 
of cell–cell adhesion, cells were subjected to shear force by passing them 
10 times through a standard 200-μl Finnpipette tip. Cells were photo-
graphed within 10 min through the AS-MDW live cell imaging workstation 
using a 10× phase-contrast objective.
Rho/Rac activity assays
MDA-231 cells were plated in 100-mm dishes. 18 h later, the cells were 
washed and incubated for an additional 12 h in serum-free media, and 
RhoA or Rac1 activities were determined as described previously (Anas-
tasiadis et al., 2000). In some cases, serum-deprived cells were treated 
with 20 ng/ml HGF for the indicated times before cell lysis. Cells were 
lysed for 5 min at 0°C in 500 μl of lysis buffer (20 mM Hepes, pH 7.5, 
0.5% NP-40, 100 mM NaCl, 0.2% deoxycholic acid, 10% glycerol, and 
10 mM MgCl2) supplemented with protease and phosphatase inhibitors. JCB • VOLUME 174 • NUMBER 7 • 2006  1096
Lysates were clariﬁ  ed with a 5-min microcentrifugation, and supernatants 
were transferred to new tubes containing 30 μg of either Rhotekin RBD or 
PAK-1 PBD (Upstate Biotechnology) bound to glutathione beads. A 20-μl 
aliquot of supernatant was also saved for the determination of total RhoA/
Rac1 and p120 levels in each sample. After a 45-min incubation at 4°C, 
beads were washed in wash buffer (20 mM Hepes, pH 7.5, 0.5% NP-40, 
100 mM NaCl, 10% glycerol, and 10 mM MgCl2), and bound RhoA- or 
Rac1-GTP, as well as total RhoA/Rac1, were visualized after SDS-PAGE 
and Western blotting using either a RhoA-speciﬁ   c mAb (26C4; Santa 
Cruz Biotechnology, Inc.) or a Rac-1–speciﬁ   c mAb (BD Biosciences). 
GTPγS- or GDP-labeled cell lysates were used as positive and negative 
controls, respectively.
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